Reckitt Benckiser Group plc (OTCMKTS:RBGLY) announced a dividend on Friday, April 30th, investing.com reports. Shareholders of record on Friday, May 7th will be paid a dividend of 0.4663 per share on Monday, June 21st. This represents a yield of 2.59%. The ex-dividend date of this dividend is Thursday, May 6th.
RBGLY stock opened at $18.35 on Tuesday. The firm has a market cap of $65.42 billion, a PE ratio of 20.39 and a beta of 0.64. Reckitt Benckiser Group has a 12 month low of $16.41 and a 12 month high of $21.00. The company has a debt-to-equity ratio of 1.12, a current ratio of 0.83 and a quick ratio of 0.62. The firm has a 50 day simple moving average of $18.31 and a 200 day simple moving average of $17.95.
A number of equities research analysts have recently commented on RBGLY shares. Jefferies Financial Group upgraded Reckitt Benckiser Group from an “underperform” rating to a “hold” rating in a research report on Wednesday, March 3rd. Sanford C. Bernstein upgraded shares of Reckitt Benckiser Group from an “underperform” rating to a “market perform” rating in a research report on Monday, February 15th. Berenberg Bank reiterated a “buy” rating on shares of Reckitt Benckiser Group in a report on Friday. Royal Bank of Canada reaffirmed a “sector perform” rating on shares of Reckitt Benckiser Group in a research note on Thursday, February 25th. Finally, Societe Generale raised Reckitt Benckiser Group from a “sell” rating to a “buy” rating in a research note on Thursday, March 4th. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $19.00.
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Story: Trade Deficit
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.